Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Influenza Vaccine in MS Patients on Teriflunomide
NCT01403376Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started Sep 2011; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01403376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01403376.